Pricing Log in Create free account

Standard BioTools Inc. (LAB) vs Profound Medical (PROF)

Standard BioTools Inc. and Profound Medical are both Medical Devices companies. Standard BioTools Inc. and Profound Medical are of similar size ($251.3M and $245.7M). Profound Medical has negative trailing earnings, so its P/E is not meaningful; Standard BioTools Inc. trades at 1.8×. Profound Medical grew revenue faster over the last twelve months: 65.3% against 35.3%. Standard BioTools Inc. has the higher net margin (157.6% vs −137.5%) and the higher return on invested capital (−54.2% vs −156.6%). Across the 18 metrics below, Standard BioTools Inc. leads on 13 and Profound Medical on 5.

Valuation

Metric LAB PROF Medical Devices median
P/E 1.80 n/m 25.58
P/S 2.89 10.63 2.54
P/B 0.44 5.91 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA 2.63 n/m 11.51
EV/Sales (2.51) 9.60 2.72
Earnings yield 55.53% (13.55%) (12.82%)
Free cash flow yield (29.61%) (12.80%) (8.18%)

Profitability

Metric LAB PROF Medical Devices median
Gross margin 52.18% 73.86% 57.76%
Operating margin (97.47%) (145.08%) (15.07%)
Net margin 157.62% (137.51%) (14.45%)
Free cash flow margin (77.76%) (133.29%) (3.88%)
Return on equity 27.86% (87.04%) (10.35%)
Return on assets 22.65% (64.68%) (17.26%)
Return on invested capital (54.18%) (156.58%) (5.27%)

Growth

Metric LAB PROF Medical Devices median
Revenue growth (TTM) 35.25% 65.26% 10.41%
EPS growth (last fiscal year) 61.54% (25.89%) 28.17%
Revenue growth, 5-year CAGR (9.19%) 17.12% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LAB PROF Medical Devices median
Debt to equity 0.00 0.11 0.04
Current ratio 9.75 4.54 2.74
Net debt to EBITDA 1.84 1.36 0.54

Dividend

Metric LAB PROF Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric LAB PROF Medical Devices median
Market cap 245.72m 251.33m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack